☰

Christine Mayr - Publications

Affiliations: 
Memorial Sloan-Kettering Cancer Center, Rockville Centre, NY, United States 
Area:
mRNA metabolism in cancer
Website:
http://www.mskcc.org/research/lab/christine-mayr
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Mayr C. 3' UTRs Regulate Protein Functions by Providing a Nurturing Niche during Protein Synthesis. Cold Spring Harbor Symposia On Quantitative Biology. PMID 31900325 DOI: 10.1101/Sqb.2019.84.039206  0.305
2019 Lee SH, Mayr C. Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. Molecular Cell. PMID 30948266 DOI: 10.1016/J.Molcel.2019.03.006  0.334
2018 Ma W, Mayr C. A Membraneless Organelle Associated with the Endoplasmic Reticulum Enables 3'UTR-Mediated Protein-Protein Interactions. Cell. PMID 30449617 DOI: 10.1016/J.Cell.2018.10.007  0.322
2018 Mayr C. What Are 3' UTRs Doing? Cold Spring Harbor Perspectives in Biology. PMID 30181377 DOI: 10.1101/Cshperspect.A034728  0.318
2018 Lee SH, Singh I, Tisdale S, Abdel-Wahab O, Leslie CS, Mayr C. Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia. Nature. PMID 30150773 DOI: 10.1038/S41586-018-0465-8  0.321
2018 Singh I, Lee SH, Sperling AS, Samur MK, Tai YT, Fulciniti M, Munshi NC, Mayr C, Leslie CS. Widespread intronic polyadenylation diversifies immune cell transcriptomes. Nature Communications. 9: 1716. PMID 29712909 DOI: 10.1038/S41467-018-04112-Z  0.377
2017 Mayr C. Regulation by 3'-Untranslated Regions. Annual Review of Genetics. PMID 28853924 DOI: 10.1146/Annurev-Genet-120116-024704  0.336
2016 Samur MK, Singh I, Shih-Han L, Sperling AS, Fulciniti M, Tai Y, Parmigiani G, Leslie CS, Mayr C, Munshi NC. 3' Untranslated Region (UTR) Alterations Are Frequently Targeted By MM-Related Mirnas and Affects the Clinical Outcome Blood. 128: 4447-4447. DOI: 10.1182/Blood.V128.22.4447.4447  0.341
2015 Mayr C. Evolution and Biological Roles of Alternative 3'UTRs. Trends in Cell Biology. PMID 26597575 DOI: 10.1016/J.Tcb.2015.10.012  0.325
2015 Berkovits BD, Mayr C. Alternative 3' UTRs act as scaffolds to regulate membrane protein localization. Nature. 522: 363-7. PMID 25896326 DOI: 10.1038/Nature14321  0.385
2015 Singh I, Samur MK, Shih-Han L, Sperling AS, Tai Y, Fulciniti M, Leslie CS, Mayr C, Munshi NC. Global 3' UTR Sequencing in Multiple Myeloma (MM) Blood. 126: 2994-2994. DOI: 10.1182/Blood.V126.23.2994.2994  0.352
2013 Lianoglou S, Garg V, Yang JL, Leslie CS, Mayr C. Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression. Genes & Development. 27: 2380-96. PMID 24145798 DOI: 10.1101/Gad.229328.113  0.323
2009 Mayr C, Bartel DP. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell. 138: 673-84. PMID 19703394 DOI: 10.1016/J.Cell.2009.06.016  0.552
2009 Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R, Debey-Pascher S, Schulz A, Frenzel LP, Claasen J, Kutsch N, Krause G, Mayr C, Rosenwald A, Plass C, et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood. 114: 3255-64. PMID 19692702 DOI: 10.1182/Blood-2009-06-229898  0.384
2009 Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R, Debey-Pascher S, Schulz A, Frenzel LP, Claasen J, Kutsch N, Krause G, Mayr C, Rosenwald A, Plass C, et al. Deregulation of miRNAs by Epigenetic Silencing Disrupts Suppression of the Oncogene PLAG1 in Chronic Lymphocytic Leukemia. Blood. 114: 3463-3463. DOI: 10.1182/Blood.V114.22.3463.3463  0.365
2008 Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. Alternative isoform regulation in human tissue transcriptomes. Nature. 456: 470-6. PMID 18978772 DOI: 10.1038/Nature07509  0.316
2008 Wiesner M, Zentz C, Mayr C, Wimmer R, Hammerschmidt W, Zeidler R, Moosmann A. Conditional immortalization of human B cells by CD40 ligation. Plos One. 3: e1464. PMID 18213373 DOI: 10.1371/Journal.Pone.0001464  0.39
2008 Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, 17, (7080-7085) DOI: 10.1073/pnas.0702409104) Proceedings of the National Academy of Sciences of the United States of America. 105: 18071. DOI: 10.1073/pnas.0809324105  0.521
2007 Bund D, Mayr C, Kofler DM, Hallek M, Wendtner CM. CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes. Experimental Hematology. 35: 920-30. PMID 17533046 DOI: 10.1016/J.Exphem.2007.03.001  0.404
2007 Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proceedings of the National Academy of Sciences of the United States of America. 104: 7080-5. PMID 17438277 DOI: 10.1073/Pnas.0702409104  0.585
2007 Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science (New York, N.Y.). 315: 1576-9. PMID 17322030 DOI: 10.1126/Science.1137999  0.513
2006 Kofler DM, Mayr C, Wendtner CM. Current status of immunotherapy in B cell malignancies. Current Drug Targets. 7: 1371-4. PMID 17073599 DOI: 10.2174/138945006778559120  0.34
2006 Bund D, Mayr C, Kofler DM, Hallek M, Wendtner CM. Human Ly9 (CD229) as novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (B-CLL) recognized by autologous CD8+ T cells. Experimental Hematology. 34: 860-9. PMID 16797413 DOI: 10.1016/J.Exphem.2006.04.010  0.406
2006 Mayr C, Bund D, Schlee M, Bamberger M, Kofler DM, Hallek M, Wendtner CM. MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes. Experimental Hematology. 34: 44-53. PMID 16413390 DOI: 10.1016/J.Exphem.2005.09.016  0.364
2006 Mayr C, Speicher MR, Kofler DM, Buhmann R, Strehl J, Busch R, Hallek M, Wendtner CM. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood. 107: 742-51. PMID 16179374 DOI: 10.1182/Blood-2005-05-2093  0.327
2005 Mayr C, Kofler DM, Büning H, Bund D, Hallek M, Wendtner CM. Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells. Blood. 106: 3223-6. PMID 16014560 DOI: 10.1182/Blood-2005-04-1742  0.387
2005 Mayr C, Bund D, Schlee M, Moosmann A, Kofler DM, Hallek M, Wendtner CM. Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. Blood. 105: 1566-73. PMID 15471955 DOI: 10.1182/Blood-2004-04-1233  0.381
2005 Kim Y, Strehl JW, Gorschluter M, Ziske C, Mayr C, Schmidt-Wolf IGH. 284. CD137L Gene Transfer Generates Effective and Long-Lasting Immunity in a Murine Plasmocytoma Model Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.287  0.316
2004 Mayr C, Schoch C, Kofler DM, Busch R, Hallek M, Wendtner C-. High incidence of new translocations in B-CLL detected by CD40L-enhanced cytogenetics (CEC): A new prognostic marker for infavorable survival outcome in patients with B-CLL Journal of Clinical Oncology. 22: 6561-6561. DOI: 10.1200/Jco.2004.22.90140.6561  0.348
2004 Mayr C, Kofler DM, Buhmann R, Strehl J, Busch R, Hallek M, Wendtner C. High Incidence of Translocations in CLL: A New Prognostic Marker for Infavorable Survival Outcome. Blood. 104: 17-17. DOI: 10.1182/Blood.V104.11.17.17  0.302
2000 Hildebrandt M, Rose M, Mayr C, Arck P, Schüler C, Reutter W, Salama A, Klapp BF. Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders. Advances in Experimental Medicine and Biology. 477: 197-204. PMID 10849747 DOI: 10.1007/0-306-46826-3_22  0.596
1999 Hildebrandt M, Rose M, Mayr C, Schüler C, Reutter W, Salama A, Klapp BF. Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders. Scandinavian Journal of Immunology. 50: 536-41. PMID 10564557 DOI: 10.1046/j.1365-3083.1999.00612.x  0.596
Show low-probability matches.